Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Indian Industry Celebrates $20.5 Billion Investment In US; Announce $1.1 Billion Projects
Indian pharmaceutical companies announced plans to invest more than $19.1 billion in the United States, anchored by Sun Pharmaceutical's planned $11.75 billion acquisition of New Jersey-based Organon & Co.
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Aditya Birla Capital Q4 FY26 Results | Wockhardt Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Q4 Results LIVE Updates: DMart shares down 4%, ideaForge Technologies up 16%; Ambuja report today
Q4 Results LIVE Updates: Amubja Cements, Manappuram Finance, Godrej Properties, Aditya Birla Capital, Tata Technologies, KEI Industries, Jindal Stainless, BHEL, Aarti Industries, Sobha, Quess Corp, Tata Chemicals, Wockhardt, are among the companies reporting their earnings today. Also watch for earnings reactions from Avenue Supermarts, Kotak Mahindra Bank, CDSL, NSDL, Zen Technologies, Mazagon Dock and others. Watch this space for all the LIVE earnings reactions.
Bombay HC backs GSK in Paxil trademark row against Shreya Life Sciences
The Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medicinal preparations. It argued that despite getting the mark more than two decades ago, Shreya Life Sciences had never used it and hence, under Section 47 of the Trade Marks Act, the registration was liable to be removed from the register of trade marks on account of non-use.
Sun Pharma 'bull' explains the benefits of the potential Organon acquisition
Macquarie believes the transaction appears strategically attractive, based on the complementary nature of the two companies’ portfolios and geographic presence.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 9 March 2026
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Aditya Birla Sun Life Amc, Aster DM Healthcare, CG Power and Industrial Solutions, Astral, and Krishna Institute Of Medical Sciencs.
Market Trading Guide: Buy Balrampur Chini and Abbott India on Thursday for gains up to 5%
The Nifty fell 1.6% amid broad-based selling triggered by the Iran-Israel conflict, with financials, auto and energy stocks leading losses. Analysts flag weak momentum and advise a sell-on-rise approach, while recommending Balrampur Chini Mills and Abbott India for short-term gains.
Elara Securities bets on pharma revival; picks Zydus Life, Sun Pharma, Aurobindo Pharma
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.
Closing Bell: Nifty below 25,200, Sensex tanks 961 pts; realty, metal, FMCG top drag
Nifty Midcap and smallcap indices down 1% each. Dr Reddy's Labs, Bharti Airtel, M&M, HDFC Life, Sun Pharma were among the top drags on the Nifty, while gainers were Trent, HCL Tech, Infosys, Apollo Hospitals. Among sectors, auto, bank, FMCG, metal, realty, telecom shed 1-2%, while IT, media, consumer durables ended in the green.
Vodafone Idea share surges 6% as Kumar Mangalam Birla backs turnaround, promoter funding plan
The stock rose as much as 5.6% to Rs 14.96 in afternoon trade after shareholders approved a Rs 4,730-crore investment from the Aditya Birla Group through a preferential allotment of warrants at an extraordinary general meeting
Trade Spotlight: How should you trade Torrent Power, Bajaj Auto, Hindustan Aeronautics, Sun Pharma, PFC, Aditya Birla Capital, and others on June 23?
The market trend remains healthy, but a sustained close above long-term moving averages is needed for further sharp upside. Below are some short-term trading ideas to consider.